Treatment of Folliculitis and Boils

Key Distinctions and Treatment Overview

Folliculitis is a superficial infection where inflammation and pus remain limited to the epidermis, while boils (furuncles) are deeper infections extending through the dermis into subcutaneous tissue with abscess formation, as noted by the Infectious Diseases Society of America 1
The American Academy of Dermatology recommends applying topical clindamycin 1% solution/gel twice daily for 12 weeks as first-line therapy for mild, localized folliculitis 2

For moderate to severe or widespread folliculitis, the American Academy of Dermatology suggests switching to oral tetracycline 500 mg twice daily for 4 months if there is an inadequate response to topical therapy after 4-6 weeks 2
The Centers for Disease Control and Prevention recommend avoiding tetracyclines in children under 8 years of age 4

The Infectious Diseases Society of America recommends incision and drainage as the primary and most effective treatment for large furuncles and all carbuncles 1
The American Academy of Dermatology suggests adding antibiotics active against S. aureus only when systemic inflammatory response syndrome (SIRS) is present or in patients with markedly impaired host defenses 1

The Infectious Diseases Society of America recommends searching for local causes such as pilonidal cyst, hidradenitis suppurativa, or foreign material in cases of recurrent abscesses 1
The American Academy of Dermatology suggests considering a 5-day decolonization regimen for recurrent abscesses, which includes intranasal mupirocin, daily chlorhexidine washes, and decontamination of personal items 1

The American Academy of Dermatology recommends using antibiotics with MRSA coverage such as trimethoprim-sulfamethoxazole, doxycycline, or clindamycin for suspected or confirmed MRSA infections 2
The Infectious Diseases Society of America suggests treating for 5-10 days initially, extending if no improvement occurs 1

The American Academy of Dermatology recommends avoiding needle aspiration for cutaneous abscesses, as it is successful in only 25% of cases overall and <10% with MRSA infections 1
The Infectious Diseases Society of America suggests avoiding topical steroids on infected areas, as they may worsen the condition 3